<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Salinero-Fort MA</submitter><funding>Agencia Laín Entralgo. Consejería Sanidad. Madrid.</funding><funding>Instituto de Salud Carlos III, Secretary of State of R+D+I and FEDER/FSE</funding><pagination>e0158489</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4956208</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(7)</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>To evaluate the performance of the Finnish Diabetes Risk Score (FINDRISC) and a simplified FINDRISC score (MADRISC) in screening for undiagnosed type 2 diabetes mellitus (UT2DM) and dysglycaemia.&lt;h4>Methods&lt;/h4>A population-based, cross-sectional, descriptive study was carried out with participants with UT2DM, ranged between 45-74 years and lived in two districts in the north of metropolitan Madrid (Spain). The FINDRISC and MADRISC scores were evaluated using the area under the receiver operating characteristic curve method (ROC-AUC). Four different gold standards were used for UT2DM and any dysglycaemia, as follows: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), HbA1c, and OGTT or HbA1c. Dysglycaemia and UT2DM were defined according to American Diabetes Asso</pubmed_abstract><journal>PloS one</journal><pubmed_title>Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.</pubmed_title><pmcid>PMC4956208</pmcid><funding_grant_id>RS_AP10/6</funding_grant_id><funding_grant_id>15/00259</funding_grant_id><funding_grant_id>12/01806</funding_grant_id><pubmed_authors>Salinero-Fort MA</pubmed_authors><pubmed_authors>Vicent-Lopez D</pubmed_authors><pubmed_authors>Abanades-Herranz JC</pubmed_authors><pubmed_authors>Lopez-Lopez S</pubmed_authors><pubmed_authors>Gomez-Campelo P</pubmed_authors><pubmed_authors>Laguna-Cuesta F</pubmed_authors><pubmed_authors>Lahoz C</pubmed_authors><pubmed_authors>Burgos-Lunar C</pubmed_authors><pubmed_authors>Sanchez-Arroyo V</pubmed_authors><pubmed_authors>Patron-Barandio P</pubmed_authors><pubmed_authors>Sabin-Rodriguez C</pubmed_authors><pubmed_authors>Garcia-Iglesias F</pubmed_authors><pubmed_authors>Fernandez-Garcia PJ</pubmed_authors><pubmed_authors>SPREDIA-2 Group</pubmed_authors><pubmed_authors>Cornejo-Del Rio V</pubmed_authors><pubmed_authors>Estirado-de Cabo E</pubmed_authors><pubmed_authors>Mostaza JM</pubmed_authors><pubmed_authors>Gonzalez-Alegre T</pubmed_authors><pubmed_authors>Montesano-Sanchez L</pubmed_authors><pubmed_authors>Fernandez-Puntero B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.</name><description>&lt;h4>Aim&lt;/h4>To evaluate the performance of the Finnish Diabetes Risk Score (FINDRISC) and a simplified FINDRISC score (MADRISC) in screening for undiagnosed type 2 diabetes mellitus (UT2DM) and dysglycaemia.&lt;h4>Methods&lt;/h4>A population-based, cross-sectional, descriptive study was carried out with participants with UT2DM, ranged between 45-74 years and lived in two districts in the north of metropolitan Madrid (Spain). The FINDRISC and MADRISC scores were evaluated using the area under the receiver operating characteristic curve method (ROC-AUC). Four different gold standards were used for UT2DM and any dysglycaemia, as follows: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), HbA1c, and OGTT or HbA1c. Dysglycaemia and UT2DM were defined according to American Diabetes Asso</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016</publication><modification>2025-04-21T15:18:45.759Z</modification><creation>2019-03-26T22:52:20Z</creation></dates><accession>S-EPMC4956208</accession><cross_references><pubmed>27441722</pubmed><doi>10.1371/journal.pone.0158489</doi></cross_references></HashMap>